Skip to main content

Share story

Science

New Zealand nuclear fusion reactor's magnetic breakthrough

New Zealand nuclear fusion reactor's magnetic breakthrough Image: Primary
OpenStar Technologies has become the first commercial company in the world to create and confine a plasma using a floating half-tonne magnet. The New Zealand-based company demonstrated the technology this week at a public event with its prototype device called Junior. Company founder and chief executive Ratu Mataira said the demonstration shows clearly that dipoles are not impossible to engineer. He noted that seeing the magnet levitate while confining plasma is a consequential step from inspired physics to tangible engineering reality. The result serves as a proof of concept that the technology is viable and can be scaled up to commercial levels. The startup aims to have commercial devices in production by the 2030s. With Junior the company has shown that dipoles have a serious place in the global fusion race. Its next prototype device Tahi will have a magnetic field four times stronger than its predecessor and will perform at up to 20 Tesla. New Zealand's government has pledged $NZ35 million to support Tahi's development. Columbia University professor emeritus Michael Mauel said the levitation of the Junior magnet marks an important milestone for superconducting magnet technology and a big step to steady fusion power.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from sciencesprings and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.